OCT 11, 2020 5:31 AM PDT

Getting Closer to a Vaccine for Flaviviruses

WRITTEN BY: Carmen Leitch

Flaviviruses or Flaviviridae like Dengue, West Nile, Zika, Japanese Encephalitis, and Yellow Fever infect over 400 million people a year. Researchers may be getting closer to developing a vaccine for these infections, which are unique in a terrible way. While exposure to an infectious agent usually triggers an immune response that enables people to fight the pathogen more efficiently if they are exposed again, flaviviruses are different. When a person is infected with a flavivirus for a second time, the antibodies that were generated after the initial infection can cause the second one to be more severe. The phenomenon is called antibody-dependent enhancement of infection, and it has confounded the development of a vaccine for Dengue and other flaviviruses.

"If at some point in the past you've had Zika virus, later when you are exposed to dengue, you are at much greater risk of getting sick. Antibodies created by memory B cells as a result of the Zika infection can bind to certain parts of the Dengue virus, but the dengue virus isn't affected," explained Deepta Bhattacharya, Ph.D., an associate professor in the University of Arizona College of Medicine - Tucson's Department of Immunobiology. "In fact, the memory B cell-generated antibodies can work like a Trojan horse and help the virus get into the cells, where it can make the disease worse."

Bhattacharya and his team began to think about developing flavivirus vaccines in another way; instead of going after an entire virus, they looked to specific portions of viruses that are specific to each type and strain. This approach would thereby take the memory B cell problem out of the equation.

"We wanted to study how the immune system and antibody responses deal with sequential exposures to different flaviviruses," Bhattacharya said. "Antibody-dependent enhancement of infection is the main reason why it has been difficult to vaccinate against flaviviruses, dengue in particular."

Reporting in Immunity, senior study author Bhattacharya and co-authors focused on plasma cells and memory B cells, which generate antibodies. Plasma cells can make antibodies after vaccination or after an infection is over, while memory B cells generate antibodies only in the case of a second infection.

"One of the questions we've had for a long time is, what is the purpose of those memory B cells?" said Dr. Bhattacharya. "If you already have antibodies from plasma cells, why do you need the other cells?"

In this study, the researchers assessed the response of memory B cells to subsequent flavivirus infections. They determined that a new infection triggers the production of diverse antibodies that can target viruses that changed after the first infection, such as through mutation. But these antibodies can make subsequent infections with other flaviviruses worse; some of them are not good at fighting an infection.

"There is a huge amount of hidden diversity in memory B cells. For most viral pathogens, like influenza or SARS-CoV-2, this is a good thing. It means that memory B cells are poised to make new antibodies and deal with mutations if and when they arise," Dr. Bhattacharya said. "For flaviviruses, this is not so great. We found that memory B cells produce a lot of suboptimal antibodies that could enhance the second infection."

It may be possible, however, to avoid this problem by developing a vaccine that does not cause the production of these diverse antibodies.

"For people already immune to one flavivirus, this would avoid engaging these not-so-great memory B cells," Bhattacharya said. "For people who never were exposed, it avoids generating this problematic diversity in the first place."

Sources: AAAS/Eurekalert! via University of Arizona Health Sciences, Immunity

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 22, 2021
Health & Medicine
Aromatherapy Spray Recalled Because of Deadly Bacterial Contamination
OCT 22, 2021
Aromatherapy Spray Recalled Because of Deadly Bacterial Contamination
The United States Consumer Product Safety Commission (CPSC) is warning people who purchased an aromatherapy spray called ...
DEC 12, 2021
Microbiology
Probiotics May Help Alleviate Nausea & Vomiting During Pregnancy
DEC 12, 2021
Probiotics May Help Alleviate Nausea & Vomiting During Pregnancy
In about 85 percent of pregnancies, nausea, constipation, and vomiting occurs, which can significantly disrupt quality o ...
DEC 16, 2021
Microbiology
Many Medications Have a Significant Impact on the Microbiome
DEC 16, 2021
Many Medications Have a Significant Impact on the Microbiome
About half of Americans have used at least one prescription drug at some point in the past thirty days, according to dat ...
DEC 18, 2021
Microbiology
All About Face Masks
DEC 18, 2021
All About Face Masks
Since the start of the pandemic, research has shown that face masks are an effective way to prevent the spread of SARS-C ...
JAN 07, 2022
Microbiology
Cells in Bacterial Biofilms Can Form Complex Patterns
JAN 07, 2022
Cells in Bacterial Biofilms Can Form Complex Patterns
These patterns are reminiscent of those seen in animal development, showing that bacteria are capable of more than we th ...
JAN 09, 2022
Cannabis Sciences
Cannabis QA: How 'Clean' Are Commercial Cannabis and Cannabis-Related Products?
JAN 09, 2022
Cannabis QA: How 'Clean' Are Commercial Cannabis and Cannabis-Related Products?
As commercial cannabis continues to gain traction in the market and popularity among consumers, the need to establish qu ...
Loading Comments...